We are live on ! Find out more
RA

Royce & Associates Portfolio holdings

AUM $10.1B
1-Year Est. Return 42.88%
This Fund
S&P 500
This Quarter Est. Return
+9.54%
1 Year Est. Return
+42.88%
3 Year Est. Return
+92.52%
5 Year Est. Return
+113.84%
10 Year Est. Return
+608.05%
AUM
$13.4B
AUM Growth
+$11.7M
Cap. Flow
-$909M
Cap. Flow %
-6.79%
Top 10 Hldgs %
8.68%
Holding
1,051
New
69
Increased
286
Reduced
463
Closed
85

Top Buys

Rank Stock Value
1
HRB icon
H&R Block
HRB
+$34.1M
2
NEWT icon
NewtekOne
NEWT
+$25.9M
3
BVS icon
Bioventus
BVS
+$25.4M
4
TGNA
TEGNA Inc
TGNA
+$24.7M
5
LPX icon
Louisiana-Pacific
LPX
+$24.6M

Sector Composition

Rank Sector Weight
1 Industrials 25.47%
2 Technology 20.75%
3 Financials 14.3%
4 Consumer Discretionary 14.11%
5 Materials 7.86%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MCHB
801
Mechanics Bancorp
MCHB
$3.65B
$1.05M 0.01%
20,115
+7,158
+55% +$345K
LVOX
802
DELISTED
LiveVox Holding, Inc. Class A Common Stock
LVOX
$1.04M 0.01%
201,729
+12,600
+7% +$69.7K
INSP icon
803
Inspire Medical Systems
INSP
$1.47B
$1.03M 0.01%
+4,488
New +$1.1M
WTFC icon
804
Wintrust Financial
WTFC
$10.7B
$999K 0.01%
11,000
LZ icon
805
LegalZoom.com
LZ
$1.45B
$996K 0.01%
+62,000
New +$1.32M
GCO icon
806
Genesco
GCO
$434M
$990K 0.01%
15,423
+3,648
+31% +$232K
EGBN icon
807
Eagle Bancorp
EGBN
$850M
$985K 0.01%
16,876
-9,056
-35% -$524K
FLGT icon
808
Fulgent Genetics
FLGT
$558M
$985K 0.01%
9,795
+4,878
+99% +$429K
BELFA icon
809
Bel Fuse Inc Class A
BELFA
$2.88B
$978K 0.01%
67,705
GBNH
810
DELISTED
Greenbrook TMS Inc. Common Shares
GBNH
$977K 0.01%
223,500
+16,598
+8% +$105K
CENT icon
811
Central Garden & Pet Co
CENT
$2.76B
$976K 0.01%
23,189
+8,314
+56% +$341K
ACTG icon
812
Acacia Research
ACTG
$437M
$975K 0.01%
190,000
CIVI
813
DELISTED
Civitas Resources
CIVI
$965K 0.01%
19,702
-8,937
-31% -$475K
NBHC icon
814
National Bank Holdings
NBHC
$1.9B
$963K 0.01%
21,915
-3,009
-12% -$131K
DIBS icon
815
1stdibs.com
DIBS
$148M
$953K 0.01%
76,200
+2,000
+3% +$27.8K
EGRX
816
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
$949K 0.01%
18,644
+1,964
+12% +$102K
NTGR icon
817
NETGEAR
NTGR
$612M
$944K 0.01%
32,315
-389,734
-92% -$11.6M
WNS
818
DELISTED
WNS Holdings
WNS
$926K 0.01%
10,500
NXGN
819
DELISTED
NextGen Healthcare, Inc. Common Stock
NXGN
$924K 0.01%
51,923
+8,940
+21% +$144K
ENVA icon
820
Enova International
ENVA
$6.09B
$916K 0.01%
22,361
-5,619
-20% -$213K
TBRG
821
DELISTED
TruBridge
TBRG
$905K 0.01%
30,891
+8,507
+38% +$278K
BRAG
822
Bragg Gaming Group
BRAG
$42.2M
$898K 0.01%
177,000
+119,000
+205% +$881K
SPTN
823
DELISTED
SpartanNash
SPTN
$858K 0.01%
33,299
-3,773
-10% -$91K
GNW icon
824
Genworth Financial
GNW
$3.86B
$854K 0.01%
210,828
-33,497
-14% -$139K
OSG
825
Octave Specialty Group
OSG
$257M
$851K 0.01%
53,000

Similar funds

Royce & Associates's Q4 2021 Portfolio in Review

As of Q4 2021, Royce & Associates held 1,051 positions worth $13.4B, up 0.09% from $13.4B the previous quarter. Its ten largest holdings account for 8.7% of the portfolio.

Royce & Associates withdrew a net $909M in Q4 2021, closing 85 positions and reducing 463 holdings. Its most notable exit was Meredith Corporation, an estimated $52.5M position sold in full.

By sector, the portfolio is most concentrated in Industrials at 25% of assets, up from 25% a quarter earlier, followed by Technology and Financials.

Against the trend, Royce & Associates opened a new position in NewtekOne worth $24.4M.

  • Royce & Associates's largest Q4 2021 buy was NewtekOne: 884,357 shares worth $24.4M.
  • Royce & Associates added most to H&R Block in Q4 2021, an estimated $34.1M increase.
  • Royce & Associates's biggest Q4 2021 reduction was Upland Software, cutting an estimated $53.8M.
  • Royce & Associates fully exited Meredith Corporation in Q4 2021, selling an estimated $52.5M.
  • Royce & Associates's ten largest holdings make up 8.7% of its $13.4B portfolio in Q4 2021.
  • Royce & Associates opened 69 new positions and closed 85 in Q4 2021.
  • Royce & Associates's portfolio value rose 0.09% quarter-over-quarter to $13.4B.

Based on Royce & Associates's 13F filing for Q4 2021, filed 7 Feb 2022.